| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 27096 |
|
200 |
190 |
$60K |
| 20550 |
|
1,011 |
907 |
$34K |
| 20553 |
|
1,459 |
1,286 |
$32K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
298 |
280 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,065 |
943 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
74 |
63 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
80 |
65 |
$2K |
| 62323 |
|
12 |
12 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
96 |
79 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
495 |
417 |
$919.16 |
| 99215 |
Prolong outpt/office vis |
183 |
163 |
$743.60 |
| 72275 |
|
12 |
12 |
$581.20 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
41 |
38 |
$45.61 |